To the content
1 . 2022

Fear of hypoglycemia - the barrier to control of type 1 diabetes mellitus

Abstract

The aim is to evaluate the indicators of glycemic variability in patients with type 1 diabetes mellitus (T1DM) with different levels of fear of hypoglycemia (FOH) in order to optimize disease management.

Material and methods. The study included 77 patients with T1DM. The patients underwent a survey on the level of fear of hypoglycemia HFS-II (hypoglycemia fear survey-II), adapted to the Russian language. Continuous glucose monitoring (CGM) was performed in 39 patients using the iPro-2 system, Medtronic.

Results. FOH was 70.25 [60.0; 81.0] points HFS-II. The glycosylated hemoglobin type A1c level in the group of patients with a low FOH was significantly lower than among patients with a high FOH and amounted to 6.98±0.98% and 8.24±1.13%, respectively (p=0.008). According to CGM, among patients with a low FOH significantly lower variability of glycemia was observed (indices SD, MAGE, CONGA, MAG, LI) in comparison with patients with a high FOH (p=0.024, 0.01, 0.008, 0.03, 0.026 respectively).

Conclusion. The level of FOH in patients with T1DM averaged 70.25 [60.0; 81.0] points out of 165. The variability of glycemia (SD, MAGE, CONGA, MAG, LI) in patients with a high FOH is significantly higher than in patients with a low FOH.

Keywords:type 1 diabetes mellitus; hypoglycemia; glycemic variability

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

For citation: Chernaya M.E., Volkova A.R. Fear of hypoglycemia - the barrier to control of type 1 diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2022; 11 (1): 33-8. DOI: https://doi.org/10.33029/2304-9529-2022-11-1-33-38 (in Russian)

REFERENCES

1. Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017. Sakharni diabet [Diabetes Mellitus]. 2018; 21 (3): 144-159. DOI: https://doi.org/10.14341/DM9686 (in Russian)

2. International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017; 40 (1): 155-7. DOI: https://doi.org/10.2337/dc16-2215. PMID: 27872155

3. McNay E.C., Cotero V.E. Mini-review: impact of recurrent hypoglycemia on cognitive and brain function. Physiol Behav. 2010; 100 (3): 234-238. DOI: https://doi.org/10.1016/j.physbeh.2010.01.004; PMID: 20096711.

4. Unger J. Educating patients about hypoglycemia prevention and selfmanagement. Clinical Diabetes. 2013; 31 (4): 179-88.

5. Starostina E.G., Moshnyaga E.N. Fear of hypoglycemia and its clinical significance: a case-control study. Sakharni diabet [Diabetes Mellitus]. 2013; 16 (3): 46-51. DOI: https://doi.org/10.14341/2072-0351-817 (in Russian)

6. Wild D., von Maltzahn R., Brohan E., et al. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns. 2007; 68 (1): 10-5. DOI: https://doi.org/10.1016/j.pec.2007.05.003; PMID: 17582726.

7. Volkova A.R., Chernaya M.E., Mozgunova V.S., et al. Impact of glycemic variability and the fear of hypoglycemia on type 1 diabetes control. Russian Medical Inquiry. 2020; 4 (6): 324-8. DOI: https://doi.org/10.32364/2587-6821-2020-4-6-324-328 (in Russian)

8. Di Battista A.M., Hart T.A., Greco L., Gloizer J. Type 1 diabetes among adolescents: reduced diabetes self-care caused by social fear and fear of hypoglycemia. Diabetes Educ. 2009; 35 (3): 465-75. DOI: https://doi.org/10.1177/0145721709333492; PMID: 19321802.

9. Nefs G., Bevelander S., Hendrieckx C., et al. Fear of hypoglycaemia in adults with type 1 diabetes: results from Diabetes MILES - the Netherlands. Diabet Med. 2015; 32 (10): 1289-96. DOI: https://doi.org/10.1111/dme.12739; PMID: 25764474.

10. Anderbro T.C., Amsberg S., Moberg E., et al. A longitudinal study of fear of hypoglycaemia in adults with type 1 diabetes. Endocrinol Diabetes Metab. 2018; 14 (2): e00013. DOI: https://doi.org/10.1002/edm2.13; PMID: 30815549.

11. Davey R.J., Stevens K., Jones T.W., Fournier PA. The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. Prim Care Diabetes. 2012; 6 (1): 35-9. DOI: https://doi.org/10.1016/j.pcd.2011.09.004; PMID: 22047939.

12. Lam A.Y.R., Xin X., Tan W.B., et al. Psychometric validation of the hypoglycemia fear survey-II (HFS-II) in Singapore. BMJ Open Diabetes Res Care. 2017; 5 (1): e000329. DOI: https://doi.org/10.1136/bmjdrc-2016-000329

13. Pontow I.M., Theil J., Diefenbacher A. Comorbidity of hypoglycaemia anxiety and panic disorder in a patient with type-1 diabetes - Combined treatment with cognitive-behavioral therapy and Continuous Glucose Monitoring (CGM) in a psychosomatic day-treatment center. Dtsch Med Wochenschr. 2020; 145 (5): 314-7. DOI: https://doi.org/10.1055/a-1038-9291; PMID: 32120406. (in German)

14. Peterkova V.A., Ametov A.S., Mayorov A. Yu., et al. The scientific advisory board resolution: Implementation of intermittently scanned continuous glucose monitoring in clinical practice to improve glycemic control. Sakharni diabet [Diabetes Mellitus]. 2021; 24 (2): 185-92. DOI: https://doi.org/10.14341/DM12753 (in Russian)

15. Chernikova N.A. Evolution of continuous glucose monitoring in existing clinical guidelines for patient with diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 59-65. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-59-65 (in Russian)

16. Glycemic variability in diabetes mellitus: monograph. 2nd ed., rev. and additional. Edited by Klimontov V.V., Myakina N.E. Novosibirsk: NSU Publishing and Printing Center; 2018. (in Russian)

17. Battelino T., Danne T., Bergenstal R.M., et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care. 2019; 42 (8): 1593-603.

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Конгресс, посвященный Всемирному дню борьбы с ожирением
Эндокринология столицы - Московский городской съезд эндокринологов
РОСМЕДОБР 2021
Вскрытие
Medicine today

XXIII Всероссийский научно-образовательный форум "Мать и Дитя − 2022" 28 - 30 сентября 2022 года в очном формате состоится XXIII Всероссийский научно-образовательный форум "Мать и Дитя − 2022" - самое значимое мероприятие для акушеров-гинекологов и смежных...

Уважаемые коллеги, приглашаем принять участие в конференции "Бронхоэктазы: муковисцидоз и не только..." в Воронеже, которая состоится с 23 по 24 июня Организаторы: · Общероссийская общественная организация "Российское общество медицинских генетиков"; · НМИЦ...

7-8 июня 2022 года "Фёдоровские чтения" объединили молодых талантливых офтальмологов Летний сезон Общество офтальмологов России открыло Всероссийской научно-практической конференцией с международным участием "Фёдоровские чтения"! Это одно из немногих российских...


Journals of «GEOTAR-Media»